long term.effects of glp-1 New Research on GLP-1s & Bone Health 🦴 ​A new large-scale study has raised questions about the long-term effects receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary What are experts learning about

While clinical trials can measure outcomes like weight loss or blood sugar reduction, they cannot yet fully capture how these networks are being reshaped with chronic drug exposure

Extend convenience into more complex treatments: Explore how DTP models could evolve beyond lifestyle and primary care into more complex disease areas with specialized support needs

Wegovy is also the only weight-loss medication approved to help reduce the risk of a major heart event, such as heart attack, stroke, or death

SOFR plus 680

And beyond gastrointestinal effects, researchers are investigating concerns about long-term impact, such as gallbladder issues, pancreatitis and potential links to thyroid tumors

Looking Ahead to 2026 and Beyond The GLP-1 weight loss landscape continues to evolve rapidly